Top Stories
The agency has issued more than 90 warning letters over the past 10 years to companies selling fraudulent cancer treatments.
/ read more /
With two acquisitions, German company Fresenius Kabi enters biosimilars market and expands in US.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
PODCAST
Jonathan Knight, vice-president of New Product Development at Cambrex Corp., discusses the environmentally friendly, economical process route that won CPhI's 2016 award for innovation in APIs and intermediates.
Listen Now |
|
|
|
|
|
advertisement
Pharmaceutical Technology's PharmaMarketplace
Your Connection to Global Pharmaceutical Manufacturing Suppliers
 Check it out today! |
|
|
Industry News
A new NIH study in rats shows that the antidepressant amitriptyline combined with drugs to treat central nervous system diseases may enhance drug delivery to the brain.
/ read more /
The agency met with EU National Competent Authorities to begin making plans for the distribution of workload because of the UK's departure from the EU.
/ read more /
More Industry News
|
|
|
Supplier News
The company increased capabilities at its Pharmatek San Diego facility in response to market demand for solubility enhancement solutions.
/ read more /
Lonza revealed it received a warning letter from FDA for its cell therapy manufacturing plant.
/ read more /
More Supplier News
|
|
|
Bio/Pharma News
GSK invests $139 million to expand production capacity for Benlysta (belimumab) in Rockville, MD.
/ read more /
The drug is approved to treat postmenopausal women with osteoporosis and is the first anabolic bone building agent approved in the US in approximately 15 years.
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
FDA sent a warning letter to Teva Pharmaceutical and Chemical (Hangzhou) Co. Ltd. after an inspection found the company failed to monitor and control quality.
/ read more /
Truxton, Inc. is voluntarily recalling one lot of Phenobarbital Tablets, USP, 15 mg because of a labeling error on declared strength.
/ read more /
More Regulatory News
|
|
|
|
MANUFACTURING
Renewable energy can improve energy efficiency and reduce carbon dioxide emissions in pharmaceutical manufacturing processes.
/ read more /
|
|
|
|
Events
May 16–18, 2017
May 21–24, 2017
June 7–8, 2017
more events |
|
|
REFERENCE BOOKS |
 |
Increase your knowledge of solid dosage technology and solid dose tablet manufacturing processes. These comprehensive pharmacology reference guides cover a variety of solid-dosage form principles such as oral solid-dosage forms, powders, mixing and blending, excipients, tableting, and coating. Drug delivery system manufacturing professionals can use the solid dosage manufacturing books to stay current with compressed tablet manufacturing processes, solid dosage processing equipment, tablet-pressing processes, and pharmaceutical industry trends in oral solid dosage manufacturing and solid dosage form development.
/ Click here /
More Reference Library |
|
|
|
eBOOKS
 |
Quality issues can appear at any stage of the bio/pharmaceutical development and manufacturing supply chain. Drug companies must monitor raw materials, suppliers, contract service providers, facilities, manufacturing processes, and production workers. In this e-book, the editors examine current quality issues, and how the industry is addressing quality challenges throughout the supply chain. |
|
|
|
|
|
